Loading...
Docoh

Health Catalyst (HCAT)

News

From Benzinga Pro
Citigroup Maintains Buy on Health Catalyst, Lowers Price Target to $25
11 May 22
News, Price Target, Analyst Ratings
Citigroup analyst Daniel Grosslight maintains Health Catalyst (NASDAQ:HCAT) with a Buy and lowers the price target from $45 to $25.
RBC Capital Maintains Outperform on Health Catalyst, Lowers Price Target to $19
11 May 22
News, Price Target, Analyst Ratings
RBC Capital analyst Sean Dodge maintains Health Catalyst (NASDAQ:HCAT) with a Outperform and lowers the price target from $35 to $19.
Health Catalyst Acquires ARMUS; Terms Not Disclosed
11 May 22
M&A
Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has acquired ARMUS
Piper Sandler Maintains Overweight on Health Catalyst, Lowers Price Target to $21
11 May 22
News, Price Target, Analyst Ratings
Piper Sandler analyst Jessica Tassan maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target from $38 to $21.
SVB Leerink Maintains Outperform on Health Catalyst, Lowers Price Target to $22
11 May 22
News, Price Target, Analyst Ratings
SVB Leerink analyst Stephanie Davis maintains Health Catalyst (NASDAQ:HCAT) with a Outperform and lowers the price target from $48 to $22.
Recap: Health Catalyst Q1 Earnings
10 May 22
Earnings
Health Catalyst (NASDAQ:HCAT) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Health Catalyst beat estimated earnings by 45.45%, reporting an EPS of $-0.06 versus an estimate of $-0.11.
Health Catalyst Q1 EPS $(0.06) Beats $(0.11) Estimate, Sales $68.09M Beat $66.02M Estimate
10 May 22
Earnings, News
Health Catalyst (NASDAQ:HCAT) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.11) by 45.45 percent. This is unchanged from the same period last year. The company reported
Earnings Scheduled For May 10, 2022
10 May 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Stocks That Hit 52-Week Lows On Thursday
5 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Thursday, 351 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
4 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Wednesday's trading, 435 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
28 Apr 22
News, Options, Intraday Update, Markets
During Thursday, 849 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
27 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
26 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Stocks That Hit 52-Week Lows On Monday
25 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Monday, 721 companies achieved new lows for the year.
Where Health Catalyst Stands With Analysts
14 Apr 22
Analyst Ratings
Over the past 3 months, 8 analysts have published their opinion on Health Catalyst (NASDAQ:HCAT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
14 Apr 22
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Upgrades
Guggenheim Initiates Coverage On Health Catalyst with Buy Rating, Announces Price Target of $39
14 Apr 22
News, Price Target, Initiation, Analyst Ratings
Guggenheim initiates coverage on Health Catalyst (NASDAQ:HCAT) with a Buy rating and announces Price Target of $39.
What 7 Analyst Ratings Have To Say About Health Catalyst
25 Mar 22
Analyst Ratings
Health Catalyst (NASDAQ:HCAT) has observed the following analyst ratings within the last quarter:
BTIG Maintains Buy on Health Catalyst, Lowers Price Target to $50
25 Mar 22
News, Price Target, Analyst Ratings
BTIG analyst David Larsen maintains Health Catalyst (NASDAQ:HCAT) with a Buy and lowers the price target from $60 to $50.
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022
17 Mar 22
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Upgrades

Press releases

From Benzinga Pro
Health Catalyst Acquires ARMUS; Bolsters Clinical Quality Offering and Outsourced Services
11 May 22
Press Releases
SALT LAKE CITY, May 11, 2022 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today
Health Catalyst Reports First Quarter 2022 Results
10 May 22
Earnings, Health Care, Press Releases
SALT LAKE CITY, May 10, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today
Health Catalyst to Announce First Quarter 2022 Operating Results and Host Conference Call on Tuesday, May 10, 2022
26 Apr 22
News, Press Releases
SALT LAKE CITY, April 26, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will
Health Catalyst, Tallahassee Memorial HealthCare Team Up to Achieve Sustainable Clinical Improvements
10 Mar 22
News, Contracts, Press Releases
SALT LAKE CITY, March 10, 2022 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to health care organizations, today
Health Catalyst Reports Fourth Quarter and Year End 2021 Results
1 Mar 22
Earnings, Health Care, Press Releases
SOUTH JORDAN, Utah, March 01, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
Temple University Health System Selects Health Catalyst's Data Platform to Help Strengthen Financial Performance and Optimize Value-Based Care
23 Feb 22
News, Contracts, Press Releases
SALT LAKE CITY, Feb. 23, 2022 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today